Showing results (21-30 of 64) with videos related to
Sort By:
Pageof 7
Biochemical Pharmacology|July 13, 2007
Functional consequences of methionine oxidation of hERG potassium channelsZhi Su, James Limberis, Ruth L Martin, et al.Journal of Pharmacological and Toxicological Methods|November 3, 2004
The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]oGilbert J Diaz, Katina Daniell, Sandra T Leitza, et al.Journal of Pathology Informatics|May 23, 2012
Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure modelsMarcin Klapczynski, Gerard D Gagne, Sherry J Morgan, et al.Journal of Cardiovascular Pharmacology|May 22, 2007
Hydroxypropyl beta-cyclodextrins: a misleading vehicle for the in vitro hERG current assayAnn Mikhail, Cristina Fischer, Ameesha Patel, et al.Neuroimage|October 7, 2006
Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesisChih-Liang Chin, Gerard B Fox, Vincent P Hradil, et al.Biochemical Pharmacology|July 6, 2010
A novel secretagogue increases cardiac contractility by enhancement of L-type Ca2+ currentZhi Su, Deborah L Widomski, Xiaoqin Liu, et al.American Journal of Physiology. Heart and Circulatory Physiology|November 6, 2007
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogsPatricia N Banfor, Lee C Preusser, Thomas J Campbell, et al.Journal of Pharmacological and Toxicological Methods|March 29, 2011
Ventricular rate adaptation: a novel, rapid, cellular-based in-vitro assay to identify proarrhythmic and torsadogenic compoundsJonathon R Green, Gilbert J Diaz, James T Limberis, et al.Journal of Pharmacological and Toxicological Methods|March 14, 2007
The effects of plasma proteins on delayed repolarization in vitro with cisapride, risperidone, and D, L-sotalolJames T Limberis, Jeff S McDermott, Heinz J Salmen, et al.Biochemical Pharmacology|May 12, 2009
Electrophysiologic characterization of a novel hERG channel activatorZhi Su, James Limberis, Andrew Souers, et al.Pageof 7